BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33787594)

  • 1. Refusal of cancer-directed surgery in male breast cancer.
    Wang S; Chen S; Huang Y; Hu D; Zeng W; Zhou L; Zhou W; Chen D; Feng H; Wei W; Zhang C; Liu Z; Wang M; Guo L
    Medicine (Baltimore); 2021 Apr; 100(13):e25116. PubMed ID: 33787594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
    Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
    Fields EC; DeWitt P; Fisher CM; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refusal of Cancer-Directed Surgery by Breast Cancer Patients: Risk Factors and Survival Outcomes.
    Gaitanidis A; Alevizakos M; Tsalikidis C; Tsaroucha A; Simopoulos C; Pitiakoudis M
    Clin Breast Cancer; 2018 Aug; 18(4):e469-e476. PubMed ID: 28784267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in treatment and survival of male breast cancer.
    Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
    J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.
    Yadav S; Karam D; Bin Riaz I; Xie H; Durani U; Duma N; Giridhar KV; Hieken TJ; Boughey JC; Mutter RW; Hawse JR; Jimenez RE; Couch FJ; Leon-Ferre RA; Ruddy KJ
    Cancer; 2020 Jan; 126(1):26-36. PubMed ID: 31588557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marital Status and Survival of Patients with Hormone Receptor-Positive Male Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
    Liu L; Chi YY; Wang AA; Luo Y
    Med Sci Monit; 2018 May; 24():3425-3441. PubMed ID: 29795054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-Year Survival after Breast-Conserving Surgery Compared with Mastectomy in Louisiana Women with Early-Stage Breast Cancer: A Population-Based Study.
    Chu QD; Hsieh MC; Lyons JM; Wu XC
    J Am Coll Surg; 2021 Apr; 232(4):607-621. PubMed ID: 33301909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer-A surveillance, epidemiology, and end results 18 population based study.
    Yin M; Verschraegen C; Vincent VH; Patel SM; George T; Truica CI
    Medicine (Baltimore); 2020 Jan; 99(3):e18745. PubMed ID: 32011455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Jan; 71():7-14. PubMed ID: 27940356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast.
    Mehdi M; Kong AL; Frebault J; Huang S; Huang CC; Cortina CS
    J Surg Res; 2021 Aug; 264():138-148. PubMed ID: 33823490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
    Yang Y; Pan L; Shao Z
    Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and survival of patients with gynecological cancers who refuse radiotherapy: a retrospective cohort study.
    Zhang S; He J; Liu J
    BMC Womens Health; 2023 Nov; 23(1):562. PubMed ID: 37915037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
    Muzaffar M; Kachare S; Vohra N
    Clin Breast Cancer; 2017 Jun; 17(3):e143-e149. PubMed ID: 27998656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of male breast cancer.
    Konduri S; Singh M; Bobustuc G; Rovin R; Kassam A
    Breast; 2020 Dec; 54():8-14. PubMed ID: 32866903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
    Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
    Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic breast cancer: Who benefits from surgery?
    Marks CE; Thomas SM; Fayanju OM; DiLalla G; Sammons S; Hwang ES; Plichta JK
    Am J Surg; 2022 Jan; 223(1):81-93. PubMed ID: 34325907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis.
    Kim YJ; Jung SY; Kim K
    Sci Rep; 2019 Jun; 9(1):8527. PubMed ID: 31189932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.